Teva Pharmaceutical Industries Limited asset turnover ratio, the ability of Teva Pharmaceutical Industries Limited's assets to generate revenue in the second quarter 2026, increased sequentially to 0.3 in the second quarter (Jun 30 2026), yet the ratio remained below the average, as TEVA's position remain challenging.

Within sector 131 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 2885 to 2937.

Asset Turnover Ratio Definition

Select the Comparisons :

None ▼

Select the Ratio:

Asset Turnover▼

None ▼

Asset Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TEVA Asset Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Asset Change	-16.73 %	6.53 %	11.09 %	0.14 %	1.56 %
Y / Y Revenue Change	-0.81 %	2.36 %	-64.55 %	3.44 %	0.29 %
Asset Turnover Ratio (TTM)	0.3	0.29	0.29	0.36	0.35
TEVA's Total Ranking	# 2937	# 2885	# 1980	# 1995	# 2403
Seq. Asset Change	-18.15 %	-5.38 %	7.16 %	0.33 %	4.72 %
Seq. Revenue Change	3.99 %	165.53 %	-66.52 %	7.28 %	7.32 %

Asset Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 132
Healthcare Sector	# 439
Overall Market	# 2937

Asset Turnover Ratio Statistics
High	Average	Low
6.03	3.78	3.07
(Jun 30 2025)		(Dec 31 2017)

TEVA Company Profile • Back to TEVA Efficiency Comparisons • Compare TEVA Asset Turnover Ratio to its Competitors

Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Asset Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Assets at quarter ending Jun 30 2026
Axogen inc	0.97	$ 251.174 Millions	$ 258.110 Millions
Orthofix Medical Inc	0.97	$ 833.344 Millions	$ 860.720 Millions
Neuropace Inc	0.97	$ 98.620 Millions	$ 102.177 Millions
Brightspring Health Services Inc	0.95	$ 5,877.918 Millions	$ 6,165.460 Millions
Ufp Technologies Inc	0.95	$ 632.042 Millions	$ 666.123 Millions
Travere Therapeutics Inc	0.95	$ 591.330 Millions	$ 624.580 Millions
Vaso Corporation	0.94	$ 80.220 Millions	$ 85.428 Millions
Apyx Medical Corp	0.94	$ 58.105 Millions	$ 62.076 Millions
Community Health Systems Inc	0.93	$ 11,983.000 Millions	$ 12,950.000 Millions
Rosecliff Acquisition Corp I	0.91	$ 16.467 Millions	$ 18.038 Millions
Embecta Corp	0.91	$ 1,019.700 Millions	$ 1,119.100 Millions
Pediatrix Medical Group Inc	0.90	$ 1,950.625 Millions	$ 2,161.685 Millions
Organogenesis Holdings Inc	0.90	$ 457.454 Millions	$ 508.749 Millions
Lakeland Industries Inc	0.90	$ 190.961 Millions	$ 212.379 Millions
Si bone inc	0.89	$ 214.331 Millions	$ 241.076 Millions
Fennec Pharmaceuticals Inc	0.89	$ 59.221 Millions	$ 66.847 Millions
Premier Air Charter Holdings Inc	0.88	$ 31.562 Millions	$ 35.785 Millions
Accuray Incorporated	0.88	$ 400.833 Millions	$ 454.583 Millions
Trisalus Life Sciences Inc	0.88	$ 45.179 Millions	$ 51.305 Millions
Ardelyx inc	0.87	$ 450.894 Millions	$ 517.044 Millions
Atricure Inc	0.87	$ 567.747 Millions	$ 652.563 Millions
Lensar Inc	0.87	$ 60.264 Millions	$ 69.354 Millions
Encompass Health Corporation	0.86	$ 6,206.100 Millions	$ 7,181.525 Millions
Regen Biopharma Inc	0.86	$ 0.237 Millions	$ 0.274 Millions
Xeris Biopharma Holdings Inc	0.86	$ 335.414 Millions	$ 389.409 Millions
Bioventus Inc	0.86	$ 581.106 Millions	$ 677.259 Millions
Protalix Biotherapeutics inc	0.85	$ 80.619 Millions	$ 94.321 Millions
Amneal Pharmaceuticals Inc	0.85	$ 3,117.474 Millions	$ 3,648.680 Millions
Cytosorbents Corporation	0.85	$ 35.663 Millions	$ 42.114 Millions
Vivos Therapeutics Inc	0.85	$ 21.135 Millions	$ 24.996 Millions

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.